Workflow
盈利预期修正
icon
Search documents
Does Alarm.com (ALRM) Have the Potential to Rally 29.41% as Wall Street Analysts Expect?
ZACKS· 2025-12-03 15:55
Shares of Alarm.com Holdings (ALRM) have gained 6.3% over the past four weeks to close the last trading session at $51.55, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $66.71 indicates a potential upside of 29.4%.The average comprises seven short-term price targets ranging from a low of $55.00 to a high of $85.00, with a standard deviation of $12.19. While the lowest estimate ...
Marvell Technology (MRVL) Tops Q3 Earnings and Revenue Estimates
ZACKS· 2025-12-02 23:21
Marvell Technology (MRVL) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.33%. A quarter ago, it was expected that this chipmaker would post earnings of $0.67 per share when it actually produced earnings of $0.67, delivering no surprise.Over the last four quarters, the company has ...
Wall Street Analysts Believe eToro Group Ltd. (ETOR) Could Rally 43.1%: Here's is How to Trade
ZACKS· 2025-12-01 15:56
Core Viewpoint - eToro Group Ltd. (ETOR) has shown a significant price increase of 13.3% over the past four weeks, with a mean price target of $60.06 indicating a potential upside of 43.1% from its current trading price of $41.97 [1] Price Targets and Analyst Consensus - The average price target for ETOR consists of 16 short-term estimates, ranging from a low of $46.00 to a high of $85.00, with a standard deviation of $11.1, suggesting variability in analyst predictions [2] - The lowest estimate indicates a potential increase of 9.6%, while the highest suggests a remarkable upside of 102.5% [2] - A low standard deviation among price targets indicates a strong agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about ETOR's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 6.2% over the past month, with two estimates increasing and no negative revisions [12] - ETOR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are often sought after by investors, they can be misleading and should not be the sole basis for investment decisions [3][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]
Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to Trade
ZACKS· 2025-11-27 15:55
Core Viewpoint - CareDx (CDNA) has shown a significant price increase of 24.7% over the past four weeks, with a mean price target of $22.8 indicating a potential upside of 28% from the current price of $17.81 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $5.54, where the lowest estimate is $14.00 (21.4% decline) and the highest is $28.00 (57.2% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about CareDx's earnings prospects, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, two estimates have been revised upward, leading to a 38.8% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - CareDx holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14]
Ambarella (AMBA) Surpasses Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-25 23:21
Core Insights - Ambarella (AMBA) reported quarterly earnings of $0.27 per share, exceeding the Zacks Consensus Estimate of $0.21 per share, and showing a significant increase from $0.11 per share a year ago, resulting in an earnings surprise of +28.57% [1] - The company achieved revenues of $108.45 million for the quarter ended October 2025, surpassing the Zacks Consensus Estimate by 4.17% and increasing from $82.65 million year-over-year [2] - Ambarella has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The sustainability of Ambarella's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.07 on revenues of $94.31 million, and for the current fiscal year, it is $0.50 on revenues of $379.82 million [7] Industry Context - The Electronics - Semiconductors industry, to which Ambarella belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Ambarella's stock may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]
NetApp (NTAP) Q2 Earnings and Revenues Beat Estimates
ZACKS· 2025-11-25 23:11
Core Insights - NetApp (NTAP) reported quarterly earnings of $2.05 per share, exceeding the Zacks Consensus Estimate of $1.89 per share, and showing an increase from $1.87 per share a year ago, resulting in an earnings surprise of +8.47% [1] - The company achieved revenues of $1.71 billion for the quarter ended October 2025, surpassing the Zacks Consensus Estimate by 1.09% and up from $1.66 billion year-over-year [2] - NetApp has outperformed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.07 on revenues of $1.71 billion, while for the current fiscal year, the estimate is $7.77 on revenues of $6.76 billion [7] - The trend of estimate revisions for NetApp was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, suggesting expected underperformance in the near future [6] Industry Context - The Computer-Storage Devices industry, to which NetApp belongs, is currently ranked in the top 19% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Workday (WDAY) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2025-11-25 23:11
Core Insights - Workday reported quarterly earnings of $2.32 per share, exceeding the Zacks Consensus Estimate of $2.13 per share, and up from $1.89 per share a year ago, representing an earnings surprise of +8.92% [1] - The company achieved revenues of $2.43 billion for the quarter ended October 2025, surpassing the Zacks Consensus Estimate by 0.70% and increasing from $2.16 billion year-over-year [2] Financial Performance - Over the last four quarters, Workday has consistently surpassed consensus EPS estimates [2] - The company has also topped consensus revenue estimates four times in the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is $2.24 on revenues of $2.51 billion, and for the current fiscal year, it is $8.84 on revenues of $9.51 billion [7] Market Position - Workday shares have underperformed the market, losing about 12.2% since the beginning of the year, while the S&P 500 has gained 14% [3] - The Zacks Industry Rank places the Internet - Software sector in the top 31% of over 250 Zacks industries, indicating a favorable outlook for the industry [8] Future Outlook - The sustainability of Workday's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The estimate revisions trend for Workday was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it will perform in line with the market in the near future [6]
Does XP Inc.A (XP) Have the Potential to Rally 32.21% as Wall Street Analysts Expect?
ZACKS· 2025-11-25 15:56
Core Viewpoint - XP Inc. (XP) shows potential for significant upside, with a mean price target of $23.48 indicating a 32.2% increase from its current price of $17.76 [1] Price Targets and Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $3.41, suggesting variability in analyst predictions [2] - The lowest estimate is $18.30, indicating a 3% increase, while the highest estimate is $30.00, suggesting a potential surge of 68.9% [2] - Analysts' price targets should be approached with caution, as they may not reliably indicate future stock prices [3][7] Earnings Estimates and Analyst Agreement - Analysts are optimistic about XP's earnings, with a consensus indicating better-than-previously estimated earnings [4][11] - Over the past 30 days, one earnings estimate has increased, leading to a 0.4% rise in the Zacks Consensus Estimate [12] - XP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Implications of Price Targets - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction [9] - While price targets should not be the sole basis for investment decisions, they can provide a useful starting point for further research [10][14]
Titan Machinery (TITN) Tops Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-25 13:56
Core Insights - Titan Machinery (TITN) reported quarterly earnings of $0.05 per share, exceeding the Zacks Consensus Estimate of a loss of $0.36 per share, but down from $0.07 per share a year ago [1] - The earnings surprise was +113.89%, following a previous surprise of +53.57% in the last quarter [2] - The company posted revenues of $644.51 million for the quarter, surpassing the Zacks Consensus Estimate by 10.77%, but down from $679.82 million year-over-year [3] Financial Performance - Titan Machinery has surpassed consensus EPS estimates three times over the last four quarters [2] - The company has topped consensus revenue estimates four times in the last four quarters [3] - The current consensus EPS estimate for the upcoming quarter is -$0.45 on revenues of $613.86 million, and for the current fiscal year, it is -$1.65 on revenues of $2.34 billion [8] Market Position - Titan Machinery shares have increased approximately 16.4% since the beginning of the year, outperforming the S&P 500's gain of 14% [4] - The Zacks Rank for Titan Machinery is currently 3 (Hold), indicating expected performance in line with the market in the near future [7] - The Automotive - Retail and Whole Sales industry, to which Titan Machinery belongs, is currently in the bottom 25% of Zacks industries, which may impact stock performance [9]
Agilent Technologies (A) Matches Q4 Earnings Estimates
ZACKS· 2025-11-24 23:20
分组1 - Agilent Technologies reported quarterly earnings of $1.59 per share, matching the Zacks Consensus Estimate, and showing an increase from $1.46 per share a year ago [1] - The company posted revenues of $1.86 billion for the quarter ended October 2025, exceeding the Zacks Consensus Estimate by 1.49%, compared to $1.7 billion in the same quarter last year [2] - Agilent has surpassed consensus EPS estimates three times and revenue estimates four times over the last four quarters [1][2] 分组2 - The stock has gained approximately 12.6% since the beginning of the year, slightly outperforming the S&P 500's gain of 12.3% [3] - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $1.41 for the coming quarter and $5.98 for the current fiscal year [4][7] - The Zacks Industry Rank places the Medical - Products sector in the bottom 36% of over 250 Zacks industries, indicating potential challenges for stock performance [8]